M&A Deal Summary |
|
---|---|
Date | 2015-12-08 |
Target | Forest Laboratories - Pharmaceutical Facilities |
Sector | Packaging |
Buyer(s) | Ropack |
Sellers(s) | Forest Laboratories |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Ropack, Inc. is a provider of contract manufacturing and packaging services for the pharmaceutical and nutraceutical industries.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Packaging) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New York) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2015) | 1 of 1 |
Category | Company |
---|---|
Founded | 1956 |
Sector | Medical Products |
Employees | 5,800 |
Revenue | 3.1B USD (2013) |
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Packaging) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (New York) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-07-02 |
Furiex Pharmaceuticals
Morrisville, North Carolina, United States Furiex Pharmaceuticals, Inc. is a drug development company focusing on treatment for gastroenterology disorders. Furiex Pharmaceuticals forms collaborations with innovators from both the biotechnology and pharmaceutical industry. |
Buy | $1.1B |